Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
12/2006
12/14/2006US20060281920 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
12/14/2006US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/13/2006EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006EP1730127A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
12/13/2006EP1730126A1 Novel benzoxazinone derivatives used as long-acting betamimetics for treating respiratory illnesses
12/13/2006CN1878762A Morpholine derivatives as norepinephrine reuptake inhibitors
12/13/2006CN1289500C Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
12/13/2006CN1289451C Di-ether used in preparation of Ziegler-Natta catalyst
12/12/2006US7148251 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
12/12/2006US7148245 Skin disorders; aging resistance of skins; antiinflammatory agents; antiallergens; rheumatic diseases; cardiovascular disorders
12/12/2006US7148223 4′-thio-L-xylo furanosyl nucleosides, precursors thereof, preparation and use thereof
12/12/2006US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006US7148217 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
12/07/2006WO2006128802A2 3-methanesulfonylquinolines as gaba-b enhancers
12/07/2006US20060276643 Amine-substituted diphenyldiphosphines
12/07/2006US20060276461 Prostaglandin analogs
12/07/2006CA2610456A1 3-methanesulfonylquinolines as gaba-b enhancers
12/06/2006EP1727809A1 Substituted morpholine and thiomorpholine derivatives
12/06/2006CN1875010A Resolution process for preparing (+)-(2s,3s)-2-(3-chlorophenyl)-3,3,3-trimethyl-2-morpholinol
12/05/2006US7145025 Structural carotenoid analogs for the inhibition and amelioration of disease
12/05/2006US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006US7144881 2-(2-fluoro-phenyl)-cyclopropanecarboxylic acid[1-(2,3-dihydro-benzofuran-5-yl)-ethyl]-amide for example; for pain, migraine, neuropathic pain, bipolar disorders, convulsions, mania, epilepsy, anxiety, depression and neurodegenerative disorders
11/2006
11/30/2006WO2006109075A3 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
11/29/2006CN1871216A Inhibitors of cathepsin s
11/28/2006US7141566 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/28/2006US7141565 Substituted quinobenzoxazine analogs
11/28/2006US7141562 Central nervous system disorders; Parkinson's disease; Huntington's diseases; antidepressants; anxiolytic agents
11/28/2006US7141560 For use as analgesic or sedative; treating sleep disorders
11/23/2006WO2006061372A3 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites
11/23/2006US20060264429 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
11/22/2006EP1723164A1 BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS
11/22/2006EP1515931B1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media
11/22/2006EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006CN1867546A Novel compound and its uses in medicine, its preparation method and its pharmaceutical composition comprising same
11/22/2006CN1865250A Benzo oxaxine intermediate containing aldehyde group and its preparation method
11/21/2006US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/16/2006WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/16/2006US20060258666 c-fms kinase inhibitors
11/16/2006US20060258649 Agronomic pesticide; less toxic; 4-imino-4H-3,1-benzoxazines e.g. N-(2-(3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl)-6-chloro-8-methyl-4H-3,1-benzoxazin-4-ylidene)methanamine
11/16/2006US20060257613 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/15/2006EP1720844A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
11/15/2006EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006CN1284776C Benzoxazine intermediate containing N-allyl and composition and preparation thereof
11/14/2006US7135495 Indole derivatives
11/09/2006WO2006117743A1 Substituted aromatic compounds as antidiabetic agents
11/09/2006US20060252958 Novel method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril
11/09/2006US20060252933 Nile red light-emitting compound, method for producing nile red light-emitting compound, and light-emitting device
11/09/2006US20060252857 Aminoaryl-1-3-5-triazines and their use as uv absorbers
11/09/2006US20060252753 N-methyl-N-[2-( 1-pyrrolidinyl)cyclohexyl]-3,4-dichlorocinnamide monohydrochloride;
11/09/2006US20060252093 Heterocyclic organic molecules through intramolecular formation of n-acyliminium ions
11/09/2006DE102005019540A1 Verfahren zur Herstellung eines Amins A process for preparing an amine
11/08/2006EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006CN1860097A Amide type carboxamide derivative
11/08/2006CN1858052A Quinolone carboxylate compounds and their preparing method and use
11/07/2006US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome
11/07/2006US7132547 Preventives/remedies for urinary disturbance
11/07/2006US7132422 An aromatic-oxy-alkyleneamine derivative, useful for treating neuropathic pain
11/07/2006US7132252 Comprises fluorophores selected from 7-hydroxycoumarin derivtives, resorufin, and a fluorescein; drug screening
11/02/2006WO2006116498A2 Purified form of tanaproget
11/02/2006US20060246228 Bifunctional photoinitiator such as 2-ethyl-2-hydroxy-1-{4-[4-(2-hydroxy-2-methyl-propionyl)-phenoxy]-phenyl}butan-1-one
11/02/2006EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006EP1716126A1 Morpholine derivatives as norepinephrine reuptake inhibitors
11/02/2006EP1654240B1 Method for production of n-aryl morpholinones
11/02/2006CA2603786A1 Purified form of tanaproget
11/01/2006CN1854139A Levo ofloxacin derivative, its production and use
10/2006
10/31/2006US7129270 Antiinflammatory agents
10/31/2006US7129247 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
10/31/2006US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor
10/31/2006US7129228 Heterocyclic analgesic compounds and methods of use thereof
10/31/2006CA2246126C New piperazine compounds
10/26/2006WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006US20060240455 Oxazine derivatives
10/26/2006DE102005018704A1 Hardenable mixture, useful for preparing hardenable product, comprises a benzoxazine compound and divinylbenzene
10/25/2006EP1265606B1 Cell adhesion inhibitors
10/25/2006CN1852902A Method for the production of 4-(4-aminophenyl)-3-morpholinon
10/24/2006US7125997 Differential tumor cytotoxicity compounds and compositions
10/24/2006US7125991 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
10/24/2006US7125871 Excitatory amino acid receptor modulators
10/24/2006CA2261848C Cell adhesion inhibitors
10/24/2006CA2252717C Colchicine-skeleton compounds, their use as medicaments and compositions containing them
10/19/2006US20060235016 Morpholine Dopamine Agonists
10/19/2006US20060235008 Novel polymorphs of efavirenz
10/18/2006EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds
10/18/2006EP1711480A1 Novel long-working beta-2-agonists and use thereof as medicaments
10/18/2006EP1711479A1 Process for the production of dtpa-bis anhydride
10/18/2006CN1847322A Colorants produced by reaction of oxyalkylene-substituted aminophenol intermediate
10/18/2006CN1847232A 2,3-dihydro-3-hydroxymethyl-[1,4]-benzoxazine derivative and its prepn process
10/17/2006US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents
10/17/2006US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/12/2006US20060229446 Structural carotenoid analogs for the inhibition and amelioration of disease
10/12/2006US20060229304 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
10/12/2006US20060229303 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example
10/11/2006EP1709017A1 Urea derivatives
10/11/2006EP1708713A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system
10/11/2006CN1845911A Condensed ring compound and use thereof
10/11/2006CN1844105A Beta-elemene derivatives containing nitrogen and their preparation method and use
10/11/2006CN1279065C Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
10/11/2006CN1279034C Dna-pk抑制剂 Dna-pk inhibitors
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 112